Russia’s Cancer Vaccine Enteromix Displays 100 Per Cent Efficacy In Clinical Trials
Last Updated:September 06, 2025, 23:11 is Enteromix, a personalized mRNA cancer vaccine, showed 100% efficacy and safety in trials. Developed by Russian institutes, it awaits Ministry of Health approval for public use. With trials completed successfully, the only remaining step is regulatory clearance. (AI-generated pic) In what could be a ground-breaking achievement in the fight…